Category: Research and Innovation

On July 16, 2024, the research team that won the Innovation Award 2024 presented their first-place award to Assoc. Prof. Charnchai Panthongviriyakul, MD, KKU President, in honor and recognition of the university’s achievements in research and innovation.

Recently, the AI For Hip Fracture Detection research team from Khon Kaen University won the regional championship in the Commercial Innovation category at the Innovation Award 2024 presented by the Ministry of Higher Education, Science, Research and Innovation. Their work featured an artificial intelligence system capable of detecting hip fractures from X-ray images with high accuracy. This AI technology has the potential to revolutionize the medical field and patient care.

The research team, led by Asst. Prof. Prin Tawinpraiand and Dr. Nattapon Tawinprai, KKU Faculty of Medicine, collaborated with the research team from the KKU Faculty of Engineering, led by Assoc. Prof. Puripong Suthisopapan. They developed an AI model that can accurately detect hip fractures from X-ray images and was recognized by the judging panel as highly creative and beneficial for medicine.

This award not only honors the research team and Khon Kaen University but also opens opportunities to apply this technology in the medical field across the Asia region. The research team is currently piloting the AI system at Srinagarind Hospital to test its effectiveness and refine it for use in other healthcare facilities.

The KKU President commented on this achievement: “Winning this award is the result of the dedication and collaboration of our team. We hope our AI technology will enhance patient care quality and reduce the workload of doctors in the future.”

Additionally, the research team is preparing to participate in the national level of the Innovation Award 2024, an important platform for showcasing the capabilities and potential of advanced AI technology. This success confirms the potential of Thai researchers and KKU in developing modern technologies that genuinely benefit society.

On February 22, 2024, KKU Faculty of Medicine held a press conference to showcase MDKKU’s leadership in synthetic research, evidence-patient treatment, and research contributions in Thailand and abroad. The press conference was led by Assoc. Prof. Apichat Jiravuttipong, MD, Dean of KKU Faculty of Medicine, Professor Pisake Lumbiganon, MD, and Associate Professor Wimorat Sriraj, MD, Associate Dean for Research and International Relations Affairs.

Assoc. Prof. Jiravuttipong said, “The Faculty of Medicine has placed importance on “Evidence–Based Medicine (EBM)” which involves selecting treatment methods using “evidence” from research. It is a discipline closely related to health technology assessment and involves several aspects. The focus is on providing it in the Faculty of Medicine curriculum. We now have over 20 years of collaboration with international organizations in conducting synthetic research in Thailand and Asia.”

Prof. Pisake Lumbiganon stated, “My team and I established the Thai Cochrane Network in 2002 before developing it into Cochrane Thailand, based in MDKKU.  We are firmly committed to producing and disseminating evidence–based research as guidelines for health care decision–making, focusing on not only local but also global impacts. Our appointment as a WHO Collaborating Centre for Research Synthesis in Reproductive Health in 2014, and as a WHO HRP Alliance Hub to strengthen research capacity for countries in the Southeast Asia Region (WHO/SEARO) in 2017, reaffirms our commitment to driving global change. We have contributed to the synthesis of more than 50 research studies to inform the development of patient care guidelines by the World Health Organization (WHO recommendations).”

He also added, “Cochrane’s strength lies in the collaborative work of Cochrane representatives from countries around the world to support the use of research evidence from Cochrane to inform health policies and practices. Additionally, we have translated over 1,000 abstracts and plain language summaries of Cochrane Reviews, because we believe language should not be a barrier to accessing health care information. Hands–on training workshops on Cochrane Reviews and using related software are provided to interested researchers both in Thailand and abroad (including Japan, Vietnam, Indonesia, Myanmar, Sri Lanka). Over the past 20 years of operation, Cochrane Thailand has received funding support from Khon Kaen University, the Thailand Research Fund or TRF, and the World Health Organization.”

Assoc. Prof. Sriraj reported, “The research Division supports evidence–based medical research alongside the development of medical personnel, aiming for doctors to choose the best and most appropriate treatments for patients based on the most reliable evidence available, leading to effective health policies and practices for all Thais to access and benefit from.”

Reporting by Sathaphorn Onlamun

Editing by Prof. John F Smith

On February 22, 2024, KKU Srinagarind Hospital held a press conference to announce the first Isan Hematopoietic Stem Cell Transplantation (HSCT) for scleroderma. The press conference was led by Assoc. Prof. Apichat Jiravuttipong, MD, Dean of KKU Faculty of Medicine, Prof. Songsak Kiatchoosakun, MD, Srinagarind Hospital Director, Prof. Chingching Fucharoen, MD, Rheumatology (Muscle and Joint) specialist, Department of Medicine, Asst. Prof. Chinadol Wanitpongpun, Hematology specialist, Department of Medicine, and Ms. TophuKhieo, a scleroderma patient at Srinagarind Hospital.

Assoc. Prof. Jiravuttipong said, “Our faculty of Medicine has been developing advanced medical technology for more efficient patient treatment, and HSCT is regarded as an example of a highly effective treatment.”

Prof. Fucharoen stated, “Scleroderma is a disease in which the immune system does not work properly, and it stimulates not only somatic cells to continuously produce collagen fibers but also fibrosis formation binding to various parts of our body. As a result, it causes tight and hard skin on the human face, fingers, toes, arms, legs, chest, and abdomen. It also affects internal organs including pulmonary and myocardial fibrosis that can lead to disability and mortality.”

She also added, “The scleroderma is mostly found in middle–aged to older people (about 40–50 years of age) and is hardly found in younger people. The global rate of scleroderma is 24:100,000 people while Isan regional rate is 40:100,000 people. According to the Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, the number of scleroderma patients in northeastern and northern Thailand is higher than other regions.”

Ms. TophuKhieo, an 18-year-old patient, started her treatment on January 2022 after initial referral to a rheumatologist. She presented with pulmonary fibrosis and HSCT treatment was started. After 14-days of treatment, her skin had softened, her skin color returned to normal and joints were more flexible. After 3 months of treatment, she could stretch out her fingers, elbows, and arms smoothly. Finally, her pulmonary fibrosis resolved and she returned to normal daily activities.

She said, “Scleroderma is a rare disease. Many people don’t know about it and how to deal with it. If you have any skin disorders or suspect you have scleroderma, you’d better see a doctor— the faster, the better.”

Asst. Prof. Wanitpongpun spoke about the HSCT procedure; “Currently, the HSCT innovation is an effective treatment alternative to help patients return to normal function. Technically, the HSCT procedure has 4 main steps. First, a thorough physical examination is performed. Second, physicians stimulate and collects stem cells. Third, high–dose chemotherapy is used to kill patients’ abnormal cells and reset the immune system. Fourth, stem cells are injected into the patients for their physical recovery.”

He also added, “HSCT is normally used in patients who are not too old and their body parts are still working well. Patients who are most affected by the disease are selected for HSCT while those who are older and have low severity don’t need HSCT.”

Prof. Kiatchoosakun’s closing speech “We would like to express our gratitude to all Srinagarind Day Fund donors. Your donations have supported us a lot in caring for low–income patients with complications and in the development of this medical technology and innovation. This case is one example of those supported by the Fund. All hopes can be supported by the power of giving. Come and be part of our Srinagarind Day Fund, Faculty of Medicine, Khon Kaen University.”

Reporting by Sathaphorn Onlamun

Editing by Prof. John F Smith

The Clinical Epidemiology Unit, Faculty of Medicine, Khon Kaen University recently held an International Short Course Training Program in Research Methodology and Biostatistics from 1 August to 30 November, 2022.  The aim of the course was to enhance statistical and methodological skills for medical research.

This course had 14 Thai physicians and 5 from Vietnam, Philippines, Cambodia, Indonesia and Iran with funding support from the National Institute of Dental & Craniofacial Research (NIDCR) & Fogarty International Center (FIC), National Institutes of Health (NIH), Award Number: 1D43DE032294-01A1.

This Short Course is part of the Medium-term training program for Clinical and Public Health Research Training in Oral Health for Southeast Asia Course, a collaborative venture between the Faculties of Medicine and Dentistry, Khon Kaen University.

Associate Professor Dr. Pattapong Kessomboon of Department of Community Medicine and Professor Dr.Banchob Sripa of the WHO Collaborating Center for Research and Control of Opisthorchiasis, Faculty of Medicine and Professor Dr.Gina Agarwal and Assistant Professor Dr.Ricardo Angeles of the Department of Family Medicine, McMaster University, Canada have jointly planned a collaborative research project to assess the effectiveness and efficiency of an enhanced community-based health education and communication approach to preventing cholangiocarcinoma. The project is financially supported by the Thai Health Systems Research Institute and the Canadian Institutes of Health Research. The project aims to generate practical knowledge that can be applied to other areas with similar problems both in Thailand and in neighboring countries. Researchers also hope to learn more about the barriers and facilitators for preventing CCA, including how culture, governance and health systems may impact the rates of infection.

Liver fluke infestation and cholangiocarcinoma (CCA) remain one of the major health problems of populations in the northeast of Thailand, as well as the neighboring countries of Laos, Vietnam and Cambodia. In Thailand alone, over 6 million people harbor the liver fluke (Opisthorchis viverrini). Infection with this parasite is the major risk factor for developing CCA. Each year 20,000 people develop CCA in Thailand alone, most of whom come from the northeast of the country. As Khon Kaen University was the first university established in the northeast region, we have a commitment to provide health care and reduce the disease burden of this cancer. Our research group was initially formed from individuals who were interested in research on liver fluke and CCA. The group has been supported by the Research Affairs of the Faculty of Medicine since 1996, and eventually evolved into the Liver Fluke and Cholangiocarcinoma Research Center (LFCRC) in 2002 on the initiative of visionary staff of the University. Members of the Center come from all health science faculties. In 2016, the Research Center was upgraded to be the Cholangiocarcinoma Research Institute (CARI) of which Dr. Khuntikeo is now the director.

CARI has the biggest CCA biobank in the world, comprising both samples from CCA patients as well as from the risk population from regional communities. We have produced more than 400 international, peer-reviewed publications and more than 150 graduate students. The Center is currently heavily involved in multidisciplinary research which is summarized below:

• Novel approaches for risk assessment of CCA and long-term measures for the prevention and control of opisthorchiasis in endemic communities
• Carcinogenesis of CCA caused by infection and inflammation in order to develop prevention and therapeutic approaches
• The development of treatment and care approaches for CCA patients to improve their quality of life
• Development of a new diagnostic platform for CCA in the northeast of Thailand

In addition, the Cholangiocarcinoma Screening and Care Program (CASCAP), led by Dr. Khuntikeo, was initiated in 2014 by Khon Kaen University with the aim of establishing a comprehensive program for the long-term control and elimination liver fluke infection and CCA. The program has the facilities summarized below:

• The Isan Cohort software (https://cloud.cascap.in.th/) was established in 2014 and has been in daily use since this time. This is an online and real-time database system used for nation-wide at-risk population registration, data recording, monitoring, evaluation and reporting to the Thai Ministry of Health, as well as to the general public. The registration and inclusion of the high-risk population takes place at primary health care hospitals. The at-risk individuals are then transferred for ultrasound screening to district hospitals and suspected CCA cases are referred for further investigation and treatment to super-tertiary care hospitals. Screening is performed simultaneously for up to 500 at risk members of the local population at the primary health care units. To date, there are more than 3,000 health care units enrolled in our diagnostic network.
• An ultrasound screening system has been developed, composed of ultrasound machines with mini-PACS, which allows the transfer of ultrasound images through the internet into the Isan Cohort database. This system also includes online-based consultation where the images can be reviewed by an expert radiologist for confirmatory diagnosis. In addition to increasing the screening capability, hepatobiliary ultrasonography training courses are offered for radiologists and general practitioners.
• Network hospitals are designated for the diagnosis and treatment of CCA and for further management of suspected CCA cases identified by ultrasound screening. This network comprises all 7 super-tertiary care hospitals in the northeast of Thailand. Moreover, hepatobiliary and pancreatic surgery training courses are provided to increase the number of specialist surgeons available to perform potentially curative or palliative surgery.

Significantly, Dr. Khuntikeo established the Cholangiocarcinoma Center of Excellence in 2015 at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, which enables patients in the first stages of the disease to undergo surgical, potentially curative, treatment. The Center has the mission to offer training to doctors, nurses and staff members in the treatment of the more than 20,000 patients from the northeast provinces if Thailand. These patients have liver fluke infection and come from large hospitals throughout the region. The center has an operation room for CCA patients as well as 2 intensive care unit beds and a patient ward for 19 people.

Furthermore, we are working together with the Data Management and Statistical Analysis Center (DAMASAC), lead by Dr. Thinkhamrop at the Faculty of Public Health, Khon Kaen Univiersity. The DAMASAC is excellent center for data management and statistical analysis for health science research who provides regular workshops on statistics, data analysis and manuscript writing for the research organizations requiring intensive regulatory environments. DAMASAC also train graduate students in data analysis and scientific writing

In 2018, The CARI in collaboration with Lao Tropical and Public Health Institute (Lao TPHI), Lao Ministry of Public Health under the support of the Kadoorie Charitable Foundation and Imperial College London (ICL) are running “Combating Cholangiocarcinoma in Lao PDR (CCAL) project, which seeks to leverage the CASCAP program to the Mekong Basin River Country of Lao PDR, where OV infection and OV-induced CCA are major public health challenges. Investment now is allow a multidisciplinary approach for the first time and with Lao PDR now awakening to the problem and the combined parasitological, zoological, water disinfection, sanitation, epidemiological, sociological and anthropological approach to disease prevention, combined with better means of disease detection with population screening, improved imaging and biomarkers for early detection – and for those with incurable cancer, improved end of life care, will allow the problem to be addressed in an integrated way for the first time. We are also aiming to expand the program to the others great Mekong sub-region countries where face the same burden.

Figure 1 The timeline for combating liver fluke and cholangiocarcinoma

CKDNET recognizes the importance of preventing and reducing kidney disease and is committed to expanding the academic roles of Khon Kaen University in solving health problems in rural areas where population may lack knowledge and access to adequate medical services.   The project is a network of cooperation between departments within Khon Kaen University, from 8 faculties (Faculty of Medicine, Faculty of Nursing, Faculty of Public Health, Faculty of Pharmacy, Faculty of Medical Technology, Faculty of Engineering, Faculty of Science and the Faculty of Agriculture), the Institute for Strategic Research and Collaboration for Northeastern Development and organizations outside the University such as the Institute of Defense Technology and the Provincial Public Health Office, hospitals, Ministry of Interior (such as Governor, Provincial Administrative Organization, District Administrative Organization, Municipality, Sub-district, Village headmen) to support medical / health sciences personnel and Village Health Volunteers, and Family Health Volunteers working on care and prevention of kidney disease. The project has ongoing government funding through Khon Kaen University, Research grants from the Thailand Science Research and Innovation (TSRI), through Program Management Unit for Competitiveness (PMUC), Office of the National Council for Higher Education, Science, Research and Innovation Policy, and the National Research Office (NRCT) since 2016.

CKDNET has carried out a number of 8 projects, [i.e., Prevention and reduction of kidney disease in urban communities; Prevention and reduction of chronic kidney disease in rural communities; Development of a rigorous and comprehensive chronic kidney disease patient care program; Cost-Effective Analysis of the Rigorous CKD Care Program; Digital Development Project for Kidney Disease Prevention; Innovative project for screening and treating chronic kidney disease; Project on study effects of environmental pollution and global warming on the occurrence of NCDs.; A population-wide assessment and treatment project for urinary tract stones for kidney disease at-risk groups and patients with kidney disease and to review of multiple strategies for maximum efficiency, and cost-savings covering the entire health service system, care and treatment system, and social welfare system, (fuller details in www.ckd.kku.ac.th and QR codes at the end of the document).

The project has mentored researchers at primary care units and hospitals in Khon Kaen Province to develop patient treatment guidelines, including new treatment approaches such as the Khon Kaen People’s Healthy Kidney Project.  This project is a collaboration between Khon Kaen University, Provincial Public Health Office, Khon Kaen Municipality, Khon Kaen Hospital, and has been presented the Governor of Khon Kaen Province, and expanded to other Northeast areas, into the 12th health zone in Southern Thailand area

CKDNET has also collaborated with the National Science and Technology Development Agency (NSTDA) through the National Electronics and Computer Technology Center (NECTEC) to develop quality innovations, such as, marker sensors for screening and monitoring symptoms of early kidney disease, via substances like “NGAL” (Neutrophil Gelatinase-associated Lipocalin) using electro-chemistry techniques, and the National Center for Nanotechnology (NANOTEC) to develop a kit for quantitative and qualitative determination of albumin in urine for point-of-care testing to prevent and slow chronic kidney disease in the community, and also to develop water quality monitoring kits, especially for heavy metal, herbicide, and pesticide contamination in Ubonrat Dam and  for 35 km along the Phong River.

Project outputs:

-A patient registration system has been created for managing patients, and test results in various medical institutions

-Training opportunity has been organized for doctors, nurses, pharmacists and information officers.

– Four MOUs have been signed, licensing 24 innovation projects, 24 titles, 29 manuscripts have been published research in international journals and 8 in national journals,

– Educational, media materials and manuals for the general public and patients have been produced in a variety of formats to suit varying age, economic and educational level and over 400,000 pieces have been distributed in communities.

– CKDNET’s products have been requested by 142 agencies from 33 provinces for patient care work.

– Seventeen agencies/organizations have requested biobank database and blood and urine samples for research.

-Three models of the “Suksala”, health check machine innovation, have been produced for application with Village Health Volunteers, patients, people at risk of kidney disease and the general public.

– A new technique for measuring NGAL biomarkers for nephrotic patients was developed.

– A model was created for community behavior change to reduce health problems in both urban and rural communities.   It included rigorous, multidisciplinary patient care training to educate health service personnel, village health volunteers, community leaders participation, and promoting community, interest and awareness of local health issue.

– Systems for village health volunteer screening and monitoring patients’ symptoms were strengthened.  This included the use of concrete practice innovations (such as reading blood pressure and sugar levels from a meter, noting urine color the color changes that represent kidney function changes, using a salinity meter for testing food salinity meter for testing salinity level.

The above are all aimed at preventing and slowing the progression of “non-communicable diseases” (NCD) and CKD, through better control of diabetes and blood pressure, and reducing smoking and alcohol consumption in the community (details in QR codes at the end of document).

In addition, CKDNET’s economic and health cost-effectiveness impacts on the country were evaluated through cost-effectiveness analysis of the project implementation, compared to normal care.  Results indicated could reduce chronic kidney disease patients’ worsening from stage 3 to 4 by approximately 75,400 people per year, and from stage 4 to 5, by about 41,300 people per year, clearly a best by intervention.

In addition, there is a basic sciences research on animals to be published on the effect of monosodium glutamate (MSG), Liver fluke infection, and changes in gut bacteria (microbiome), on the kidney pathology development.

Future plans include developing a seamless, sustainable remote health system (KKU CKD Telehealth platform) connection model for health care from the community primary care to tertiary hospital care.  This will be specific for kidney disease and “non-communicable diseases” patients using web and mobile applications combined with some CKDNET project innovations.  This will extend the CKDNET hospital registry system for using by Village Health Volunteers for reporting on individual patient health outcomes (via Raktai Application), including public health measurement data from the Suk-sala machine.   This KKU CKD telehealth system will promote multidisciplinary care and integrates treatment, prevention, health promotion, and health restoration whilst making travel and other practice-cost savings.

Further research will focus on the impact of water pollution and agrochemical contamination on kidney disease incidence in rural communities, especially idiopathic kidney and other related diseases.

A joint project with NANOTEC plans to develop screening innovations for early kidney disease with further albumin analysis kits: portable quantitative and semi-quantitative urine creatinine kits.  It is also planned to develop economically prices sensors for detecting small quantities of drinking water chemical contaminants by focusing on easily use inspection techniques.  For example, to detect level of ferrous metals (Fe), manganese (Mn), aluminum (Al) and pesticides, including glyphosate and paraquat, in the local areas.  There is an existing sensors technology base that can be developed for local and rural use to monitor and improve water quality.

CKDNET project has already surveyed and found that households and community water sources quality is lower standard in some of these areas.  Local innovations through community and industrial sites collaboration could test effective pragmatic practice to rectify this situation, which could then be further developed into a national policy.

ภาคผนวก

สรุปผลงาน CKDNET

1.รวมสื่อประชาสัมพันธ์ CKDNE

https://drive.google.com/drive/u/0/folders/1QcC55z26LjdRuAkN6J5-iMN1oDSh_cDP

2. ผลงานลิขสิทธิ์ จำนวน 24 เรื่อง

https://drive.google.com/drive/u/0/folders/1tYxOE8_JwDqBOUcr0xatJtGd2soSe4-F

3.วารสารโครงการ CKDNET

https://drive.google.com/drive/u/0/folders/1tnJZ4N2a_K-6gAkNrp-m8mj_VUmC5TYW

4.วารสารฉบับพิเศษ

https://drive.google.com/drive/u/0/folders/1MY87prBOFWghZO9NWslz85wM1PJDXzOO

5.CKDNET paper

https://drive.google.com/drive/u/0/folders/1e3KxQ9RqkFeF0nTHxgS1GT4IGe87nqwB

6.คลิป VDO นวัตกรรมตู้ตรวจสุขภาพอัจฉริยะ “สุขศาลา”

https://drive.google.com/drive/u/0/folders/1fiK9jRTLEfHA9KX1jgJqaE2j4lk-pzvT

7.สรุปงานภาพรวม CKDNET

https://drive.google.com/drive/u/0/folders/1oJVzfRfvkmoPeYLl3VSpCJltZ36xFGJ

รูปภาพประกอบ

คณะผู้ร่วมโครงการป้องกันและชะลอโรคไตในภาคตะวันออกเฉียงเหนือ (Chronic Kidney Disease Prevention in the Northeast of Thailand: CKDNET)

สรุปการดำเนินงานตั้งแต่ พ.ศ. 2559-ปัจจุบัน

การสร้างรูปแบบป้องกันโรคไตในชุมชน และคัดกรองโรคไตเรื้อรังและปรับเปลี่ยนพฤติกรรม

นวัตกรรมในการตรวจคัดกรองและติดตามอาการผู้ป่วยโรคไต

การสำรวจมลภาวะทางน้ำและพัฒนาชุดตรวจวัดคุณภาพของแหล่งน้ำและน้ำที่ใช้ในครัวเรือนภายใต้โครงการ อว. เพื่อสำรวจปัญหาสุขภาพและคุณภาพน้ำ ในแหล่งน้ำและน้ำที่ใช้สำหรับอุปโภค-บริโภค ในพื้นที่เขื่อนอุบลรัตน์และอำเภอน้ำพอง  จังหวัดขอนแก่น

Changes in contemporary society and families have had immense impacts on lifestyles, adjustments, and mental health. Particularly, medical students could have accumulated stress from study, unachieved academic performance, and other problems or factors, including   family, social, personal, and economic issues. These could also include interpersonal issues, which affects mental health of students and in turn reflects on their academic achievement.

Recent statistical data shows mental health problems among medical students are increasing. The number of medical students who received mental health therapy in 2018 and 2019 increased by 1.57 and 1.92 times over 2017, respectively. The Division of Academic Affairs, Faculty of Medicine, Khon Kaen University is therefore initiating the MedMind KKU project to address the mental health problems of students in the faculty via early detection and early management.

Project objectives

1. To provide counseling assistance for mental health problems and self-management for students in the faculty.
2. To strengthen knowledge about mental health for students and relevant personnel (adviser, administrative personnel).

Service Model

1. Individual counselling and therapy by psychiatrists and psychologists for students with mental health difficulties and academic pressure.
2. Counselling in partnership with family for students with complicated problems or repeated academic hardships.
3. Integration with teaching and learning processes by opening new course “Life management” for medical and other students.
4. Networking and engagement with students—e.g., encouraging medical students to participate in early detection and submitting articles to share their life experiences.
5. Development of e-leaning course “counselling” for instructors.   

Access to services

Students will be able to directly contact the staff of MedMind KKU. In addition, the service can be provided for students on recommendation and referral by advisers; and by proactive search based on academic performance of medical students.

Khon Kaen University doctor proposes the research work from which the Government authorizes reduction of medical expense for patients with cerebral aneurism. Patients can now have more access to treatment. Cases of disabilities from the disease or death will decrease.

Cerebral aneurysm is the disease that urges the patient to visit the doctor when they have cerebral hemorrhage, which is a condition requiring immediate treatment, for the hemorrhage risks recurring that can lead to death or disability. Treatment may involves operation for clipping the aneurism or coiling, depending on each patient’s lesion. Nowadays, treatment can be done by placing spring coils, which result in good outcome and leave a small cut, as well as more possibility to be done in difficult area; however, with relatively higher expense.

Up to now, the patients having the gold health security card in Thailand cannot be reimbursed for the treatment of this disease. Therefore, these patients do not have access to treatment by spring coiling owing to limitations in terms of budget. This means the operation has to be done by skull opening, which may not be effective as expected. Moreover, this kind of operation risks disability and death.

Srinagarind Hospital of Khon Kaen University, by the Center of Excellence for Cerebral Aneurysm has produced research work on the worthiness of treatment with coiling for this disease. The project has been supported by the Health System Research Institute (HSRI). The researchers collected retrospective data from the patients in Thailand for over 10 years and the data of Srinagarind Hospital patients for over 5 years. The qualitative research analyses were conducted and the result showed that the treatment of the disease with coiling is worthwhile and can reduce the rates of disability and death.

Doctor Pitchayen Duangthongphon, a neurological expert of Srinagarind Hospital related, “The research team of the study project on the worthiness of treatment with coiling for this disease analyzed the data before Assoc. Prof. Amnat Kitkhuandee, M.D. presented the result at the National Health Security Office that the study verifies the worthiness of the treatment with this method. NHSO thus approved the project and now authorizes the patients holding the gold health security card to receive medical treatment fee for operation with coiling as of October 1, 2021. NHSO’s announcement says that the coiling can be reimbursed at an amount of more than 10,000 baht per coil. One patient needs 4 coils and so the reimbursement amounts to over 50,000 baht. Formerly, patients holding this card could not be reimbursed and had to pay over 100,000 baht for the overall treatment.”

Assoc. Prof. Amnat Kitkhuandee, M.D., an expert in neurological surgery of Srinagarind Hospital said, “Srinagarind Hospital established the Center of Excellence for Cerebral Aneurysm with an aim to bring the utmost benefit to the people, for each year there are more than 100 cases of patients with this disease coming to Srinagarind Hospital, who need to be operated on. Only 10% of these patients can receive treatment by coiling, for the surgery expense is roughly 100,000 baht. This is a problem if the patient cannot afford it, and it means some patients do not have access to medical treatment. This limitation was the rationale behind the research project, and the outcome shows the worthiness of the treatment of this disease by the coiling method, especially when thinking in terms of the disability or death the disease may cause. One part of this research has been accepted for publication in the Journal of NeuroInterventional Surgery, which has the Q1 Impact factor of 5.836.”

Therefore, patients holding the gold health security card can from October 1 this year be reimbursed for the operation with coiling. The research on the worthiness of cerebral aneurysm treatment with coiling is truly useful for patients who have constraint in health coverage. Thanks to the National Neurological Surgery College under the Royal Patronage for the support of the project.

Support content : https://www.kku.ac.th/12067

Thailand Scientist and University Rankings 2021 by AD Scientific Index show 2 MD-KKU scientists are among the Top 25 in Thailand;

1. Professor Banchob SRIPA, PhD, ranked 15^th
2. Professor Paiboon SITHITHAWORN, PhD, ranked 25

These rankings are based on the work 2,306 scientists from 135 institutions in Thailand.

https://www.adscientificindex.com/?country_code=th&fbclid=IwAR0HkIyzbXikneIRczfqhvYIiygJQUdt1kUqI9OoumhHj34ry3LJ4CdeIk0

Biography

Professor Banchob Sripa

WHO Collaborating Centre for Research and Control of Opisthorchiasis (Southeast Asian Liver Fluke Disease) – Tropical Disease Research Center, Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. Tel: +66-43-363113, E-mail: banchob@kku.ac.th

Professor Banchob Sripa is a Senior Research Scholar, the Head of the WHO Collaborating Centre for Research and Control of Opisthorchiasis (Southeast Asian Liver Fluke Disease), and Director of the Tropical Disease Research Center, Department of Pathology, Faculty of Medicine, Khon Kaen University, Thailand. Currently, Dr.Sripa is a panel member of the WHO Foodborne Disease Burden Epidemiology Reference Group (FERG2). He got a highest doctoral degree in Tropical Health from the University of Queensland (Australia) and experienced several post-graduate trainings in pathology and global health.  He has been working as lecturer both undergraduate and graduate study for >30 years with over 50 MSc and PhD under his supervision. His research focus is mainly on human liver fluke in several aspects including its related cholangiocarcinoma (CCA), the bile duct cancer as well as other tropical diseases. Dr.Sripa is a world expert in pathology, pathogenesis and control of liver fluke infection and CCA. His integrated liver fluke control program named “Lawa model” is one of the two showcases with success helminth control of WHO/NZD4 (2015).  Dr. Sripa has >260 research articles, viewpoints, editorials and reviews in peer reviewed international journals and book chapters recently in Nature Genetics, Lancet Oncology, Lancet Infectious Diseases, Trends Parasitology, Cancer Science, Hepatology, Proteomics, PLOS Pathogens, Scientific Reports, Advances in Parasitology and elsewhere with high citation index, h = 50.  He was ranked as world expert in cholangiocarcinoma (2019), Helminths (2019) and Opisthorchiasis (2019-2021) by ExpertScape and among world top 2% scientists in Mycology and Parasitology by Stanford University (2020). He sits on the Deputy Editor of PLOS Neglected Tropical Diseases, Associate Editor of Tropical Medicine & International Health, and editorial boards of Infectious Diseases of Poverty (BMC Journal), Acta Tropica (Elsevier), J. Helminthology (Cambridge) and Tropical BioMedicine.  He is a Chief Guest Editor/Volume editor for 5 Special Issues on liver flukes in Acta Tropica (2003), Parasitology International (2012), Parasitology International (2017), Advances in Parasitology (2018), and Acta Tropica (2021). He has received several scientific research awards, the most prestige the Thailand Outstanding Scientist Award from the Foundation for the Promotion of Science and Technology under the Patronage of H.M. the King – the King Award (2013) and the Thailand Research Fund Senior Research Scholar (2013).  Dr.Sripa is a former panel member of the WHO’s International Agency for Research on Cancer (IARC) panel of experts for biological agents of cancer, Disease Reference Group on Helminths (DRG), Foodborne Disease Burden Epidemiology Reference Group (FERG1), WHO advisers, and ex- President of the Regional Network of Asian Schistosomiasis and Other Helminth Zoonoses (RNAS+).